Ensign Peak Advisors, Inc Kal Vista Pharmaceuticals, Inc. Transaction History

Ensign Peak Advisors, Inc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 12, 2021	SELL	$17.11 - $24.49 $806,154 - $1.15 Million	-47,116 Closed	0 $0
Q1 2021 May 12, 2021	BUY	$14.69 - $42.57 $431,680 - $1.25 Million	29,386 Added 165.74%	47,116 $1.21 Million
Q4 2020 Feb 12, 2021	BUY	$12.88 - $19.47 $228,362 - $345,203	17,730 New	17,730 $337,000
Q3 2020 Nov 12, 2020	SELL	$9.83 - $13.99 $41,806 - $59,499	-4,253 Closed	0 $0
Q1 2020 May 11, 2020	SELL	$5.8 - $18.56 $24,667 - $78,935	-4,253 Reduced 50.0%	4,253 $33,000
Q4 2019 Feb 14, 2020	BUY	$10.31 - $17.81 $87,696 - $151,491	8,506 New	8,506 $151,000

125

47.8M

551K

110K

Ticker KALV
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 24,602,000
Market Cap $248M
Description
KalVista Pharmaceuticals, Inc., a clinical stage pharmaceutical company, discovers, develops, and commercializes small molecule protease inhibitors for diseases with unmet needs. The company's product portfolio comprises small molecule plasma kallikrein inhibitors targeting hereditary angioedema (HAE) and diabetic macular edema (DME); and oral p...

Get notified when there are updates to the investment portfolio of Ensign Peak Advisors, Inc, based on Form 13F filings with the SEC.

Stay updated on Ensign Peak Advisors, Inc with notifications on news.